Genetic skin disorders: The value of a multidisciplinary clinic.
genetic skin disorder
genodermatosis
multidisciplinary clinic
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
07
01
2021
received:
25
03
2020
accepted:
12
01
2021
pubmed:
28
1
2021
medline:
7
8
2021
entrez:
27
1
2021
Statut:
ppublish
Résumé
Genodermatoses are inherited disorders with skin manifestations and can present with multisystem involvement, resulting in challenges in diagnosis and treatment. To address this, the expertise of dermatology and clinical genetics through a multidisciplinary clinic (Genodermatoses Clinic) were combined. A retrospective cohort study of 45 children seen between March 2018 and February 2019 in the Genodermatoses Clinic at The Children's Hospital of Philadelphia was performed. Patient demographics, referral information, genetic testing modality, diagnoses, and patient satisfaction scores were evaluated to assess the clinic's impact. The majority of patients (42.2%) were referred from Dermatology and 86.7% were referred for diagnosis. Two-thirds of the patients were recommended genetic testing, and subsequently 73.3% completed testing. Nearly three-quarters, 26 out of 36 patients (72.2%), of our undiagnosed patients received a clinical and/or molecular diagnosis, which is imperative in managing their care. Twenty-two individuals pursued genetic testing. In eight individuals (36%), molecular testing was diagnostic. However, in two individuals the molecular diagnosis did not completely explain the phenotype. However, there are still obstacles to genetic testing, such as cost of testing and insurance barriers. Almost all (91.4%) rated the Genodermatoses Clinic as "Very Good," the top Press Ganey score. High patient satisfaction scores suggest a positive impact of the Genodermatoses clinic, emphasizing the importance to increase support for the clinical and administrative time needed for patients with genodermatoses.
Identifiants
pubmed: 33502802
doi: 10.1002/ajmg.a.62095
pmc: PMC8683660
mid: NIHMS1752742
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1159-1167Subventions
Organisme : NCATS NIH HHS
ID : TL1 TR001880
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001878
Pays : United States
Organisme : National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health
ID : UL1TR001878
Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
J Dtsch Dermatol Ges. 2016 Oct;14(10):969-986
pubmed: 27767270
J Cutan Med Surg. 2018 Jan/Feb;22(1):44-50
pubmed: 28689431
Pediatr Dermatol. 2017 Jan;34(1):33-38
pubmed: 27653748
J Cutan Med Surg. 2016 Sep;20(5):486-9
pubmed: 27207352
Hautarzt. 2015 Mar;66(3):203-11; quiz 212-3
pubmed: 25691341
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Am J Hum Genet. 2017 May 4;100(5):695-705
pubmed: 28475856
Genet Med. 2019 Dec;21(12):2798-2806
pubmed: 31239560
Clin Transl Sci. 2018 Jan;11(1):21-27
pubmed: 28796445
Am J Med Genet A. 2020 Apr;182(4):746-754
pubmed: 31961058
Biotechnol Healthc. 2004 Sep;1(4):30-44
pubmed: 23397379
Neurogenetics. 2018 May;19(2):105-110
pubmed: 29589152
Dermatol Clin. 2016 Jul;34(3):303-10
pubmed: 27363887